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Abstract
Objective—This study investigated predictors and moderators of mood symptoms in the
randomized controlled trial (RCT) of Multi-Family Psychoeducational Psychotherapy (MF-PEP)
for childhood mood disorders.
Method—Based on predictors and moderators in RCTs of psychosocial interventions for
adolescent mood disorders, we hypothesized that children’s greater functional impairment would
predict worse outcome, while children’s stress/trauma history and parental expressed emotion and
psychopathology would moderate outcome. Exploratory analyses examined other demographic,
functioning, and diagnostic variables. Logistic regression and linear mixed effects modeling were
used in this secondary analysis of the MF-PEP RCT of 165 children, ages 8–12, with mood
disorders, a majority of whom were male (73%) and White, non-Hispanic (90%).
Results—Treatment nonresponse was significantly associated with higher baseline levels of
global functioning (i.e., less impairment; Cohen’s d = 0.51) and lower levels of stress/trauma
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history (d = 0.56) in children and Cluster B personality disorder symptoms in parents (d = 0.49).
Regarding moderators, children with moderately impaired functioning who received MF-PEP had
significantly decreased mood symptoms (t = 2.10, d = 0.33) compared with waitlist control. MF-
PEP had the strongest effect on severely impaired children (t = 3.03, d = 0.47).
Conclusions—Comprehensive assessment of demographic, youth, parent, and familial variables
should precede intervention. Treatment of mood disorders in high functioning youth without
stress/trauma histories and with parents with elevated Cluster B symptoms may require extra
therapeutic effort, while severely impaired children may benefit most from MF-PEP.
Keywords
family psychoeducation; predictor; moderator; children; mood disorders
Although randomized controlled trials (RCTs) are the “gold standard” for evaluating
treatment efficacy, much more can be learned from an RCT than is often reported in the
literature (Kraemer, Wilson, Fairburn, & Agras, 2002, p. 877). Specifically, RCTs can help
improve the efficacy and transportability of treatments by establishing an empirical basis for
treatment manuals, matching clients to interventions, and maximizing operative mechanisms
of change (Kraemer et al., 2002). However, few studies have examined the mechanisms
(mediators) and conditions (moderators) associated with treatment-induced change (Nock,
2003; Paul, 1967).
Predictor and moderator analyses can provide valuable information regarding selection of
optimal treatment for individuals, based on pretreatment clinical presentation and
characteristics. Predictor analyses seek to identify variables that predict a positive versus
negative response and that reflect a main effect on outcome, regardless of treatment group.
Moderator analyses, on the other hand, investigate whether the effects of one intervention,
versus another, are conditional on certain characteristics, with moderation operationalized as
a statistical interaction between baseline characteristics and the intervention effect
(Hinshaw, 2002; Kraemer et al., 2002). Thus, predictors are indicators of general prognosis,
while moderators are prescriptive and can identify groups who are differentially responsive
to a specific treatment, potentially revealing for whom an intervention may be particularly
well-suited and for whom extra therapeutic effort may be required (Hinshaw, 2002).
Predictors and Moderators in RCTs for Adolescent Mood Disorders
Although research has identified a number of psychosocial Evidence-Based Treatments
(EBTs) for youth with mood disorders, few studies have investigated the predictors and
conditions associated with successful intervention (David-Ferdon & Kaslow, 2008; Fristad
& MacPherson, 2013). This gap in research led the National Institute of Mental Health
Workgroup on Psychosocial Intervention Development for Mood Disorders to identify the
study of moderators of psychotherapy as a research priority (Hollon et al., 2002).
Several RCTs of EBTs for adolescents with diagnosed depression identified baseline
predictors of mood outcome, including demographic, youth functioning, and family
functioning variables. Regarding demographics, four studies found older adolescent age
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predicted worse outcome (Brent et al., 1998; Clarke et al., 1992; Curry et al., 2006; Jayson,
Wood, Kroll, Fraser, & Harrington, 1998), though one study found the opposite (Rohde,
Seeley, Kaufman, Clarke, & Stice, 2006). Sex and race did not predict immediate outcome,
though one study found females were more likely to relapse (Curry et al., 2011).
In terms of youth functioning, worse mood outcome was predicted by higher levels of
depression symptom severity (Asarnow et al., 2009; Birmaher et al., 2000; Brent, Kolko,
Birmaher, Baugher, & Bridge, 1999; Brent et al., 1998; Clarke et al., 1992; Curry et al.,
2006; Emslie et al., 2010; Vitiello et al., 2011; Wilkinson, Dubicka, Kelvin, Roberts, &
Goodyer, 2009), melancholic features (Curry et al., 2006), functional impairment (Asarnow
et al., 2009; Curry et al., 2006; Emslie et al., 2010; Jayson et al., 1998; Rohde et al., 2006;
Vitiello et al., 2011; Wilkinson et al., 2009), hopelessness (Asarnow et al., 2009; Brent et
al., 1998; Curry et al., 2006; Emslie et al., 2010; Rohde et al., 2006; Wilkinson et al., 2009),
suicidal ideation (Asarnow et al., 2009; Curry et al., 2006; Rohde et al., 2006; Wilkinson et
al., 2009), non-suicidal self-injury (NSSI; Asarnow et al., 2009; Vitiello et al., 2011),
cognitive distortion (Brent et al., 1998), and negative or irrational thoughts (Clarke et al.,
1992; Rohde et al., 2006), as well as lower levels of enjoyment and pleasant activities
(Clarke et al., 1992), coping skills (Rohde et al., 2006), expectations for improvement
(Curry et al., 2006), and treatment with selective-serotonin reuptake-inhibitors (SSRIs;
Asarnow et al., 2009).
In addition, most studies identified higher number of comorbid diagnoses (Asarnow et al.,
2009; Curry et al., 2006; Wilkinson et al., 2009), comorbid dysthymia (Brent et al., 1999;
Emslie et al., 2010), comorbid or high anxiety (Brent et al., 1998; Clarke et al., 1992; Curry
et al., 2006; Emslie et al., 2010; Wilkinson et al., 2009), comorbid or high disruptive
behaviors (Brent et al., 1999; Rohde, Clarke, Lewinsohn, Seeley, & Kaufman, 2001; Rohde
et al., 2006), comorbid attention-deficit/hyperactivity disorder (ADHD; Rohde et al., 2001;
Rohde et al., 2006), and substance abuse/dependence (Rohde et al., 2001; Vitiello et al.,
2011) as predictors of worse outcome. In contrast, Clarke et al. (1992) found greater number
of psychiatric comorbidities predicted better outcome, and Rohde et al. (2001) found
comorbid anxiety was associated with greater improvement in depression.
Concerning family functioning, worse outcome was predicted by family difficulties in
affective involvement (Brent et al., 1999) and conflict (Asarnow et al., 2009; Brent et al.,
1999; Birmaher et al., 2000; Emslie et al., 2010; Feeny et al., 2009), low cohesion (Rohde et
al., 2006), and parent noninvolvement (Clarke et al., 1992).
Several moderators of mood outcome were also identified in RCTs of EBTs for depressed
adolescents. Similar to aforementioned treatment predictors, many moderators can be
conceptualized as demographic, youth functioning, and family functioning variables.
However, novel moderators, such as stress/trauma and parental psychopathology, have also
emerged in the adolescent depression literature. An examination of Cognitive Behavioral
Therapy (CBT), Systematic Behavioral Family Therapy, and Nondirective Supportive
Therapy (NST) found that adolescents with comorbid anxiety responded better to CBT than
other treatments, while efficacy of CBT diminished in presence of maternal depression
(Brent et al., 1998). Suicidal, depressed adolescents responded better to CBT versus NST,
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relative to non-suicidal youth (Barbe, Bridge, Birmaher, Kolko, & Brent, 2004a). Also, CBT
was more efficacious than NST in the absence of sexual abuse, but was not superior to NST
for those with a sexual abuse history (Barbe, Bridge, Birmaher, Kolko, & Brent, 2004b). In
addition, evaluation of the Adolescents Coping with Depression Course (CWD-A) versus a
Life Skills/Tutoring Control (LS) found CWD-A resulted in faster recovery time, relative to
LS, among adolescents who were Caucasian, had recurrent depression, and had good coping
skills (Rohde et al., 2006). Further, benefits of Interpersonal Psychotherapy versus treatment
as usual (TAU) were strongest for adolescents with high levels of conflict with their mothers
and social dysfunction with friends (Gunlicks-Stoessel, Mufson, Jekal, & Turner, 2010).
In the Treatment for Adolescents with Depression Study (TADS), which examined efficacy
of fluoxetine, CBT, CBT + fluoxetine, and clinical management + pill placebo, combined
treatment was more efficacious than fluoxetine for mild to moderate depression and for
depression with high levels of cognitive distortion (Curry et al., 2006). Combined treatment
and fluoxetine were equally effective for severe depression or depression with low levels of
cognitive distortion. In addition, fluoxetine and combined treatment were equally effective
for adolescents from low- or middle-income families, whereas the three active treatments
were equivalent for adolescents from high-income families, though only combined treatment
and CBT significantly surpassed control. Also, those with ADHD demonstrated similar
improvements in all active treatments compared with control, whereas only CBT +
fluoxetine was superior to control for those without ADHD (Kratochvil et al., 2009). In
addition, adolescents from negative familial environments (i.e., disagreement on values/
norms, poor communication, and dysfunctional levels of involvement and control) were
more likely to benefit from fluoxetine alone, while youth with better family functioning
benefited more from combined treatment (Feeny et al., 2009). Finally, trauma history also
moderated treatment response (Lewis et al., 2010). Youth without trauma responded equally
well to combined treatment and fluoxetine, both of which were more effective than CBT and
control. Youth with trauma and physical abuse histories responded equally well to the four
treatment conditions. However, teens with histories of sexual abuse who received combined
treatment, fluoxetine, and control showed significant and equivalent improvement in
depression, while youth who received CBT did not experience similar improvement.
In the Treatment of Resistant Depression in Adolescents (TORDIA) study, which focused
on second-step treatment strategies (12 weeks of a medication switch and CBT or a
medication switch alone) among adolescents with SSRI treatment-resistant depression,
response to combined treatment was more likely among youth with no abuse history, lower
levels of hopelessness, and more comorbid disorders (with a marginally significant effect for
comorbid ADHD; Asarnow et al., 2009). Adolescents who were older, Caucasian, without
NSSI, and with comorbid anxiety disorders and longer pharmacotherapy histories also
experienced more benefit from combined treatment versus medication alone. When
examining specific aspects of abuse history, Shamseddeen et al. (2011) found that those
without physical or sexual abuse histories had a higher response to combination therapy than
medication alone. Those who had been sexually abused demonstrated similar response to
combination treatment and medication alone, while those who had been physically abused
had a lower response to combination therapy.
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Only one RCT of adolescents with bipolar disorders examined family functioning
moderators of treatment. In an RCT of Family-Focused Treatment for Adolescents (FFT-A)
versus brief psychoeducational treatment, Miklowitz et al. (2009) found parental expressed
emotion (EE; criticism, hostility, and emotional overinvolvement) moderated the impact of
FFT-A on mood symptoms. Adolescents in high-EE families showed greater reductions in
depressive and manic symptoms in FFT-A than in brief psychoeducational treatment,
suggesting that parental EE moderates the impact of family intervention on symptoms of
youth bipolar disorder.
Thus, several predictors and moderators related to demographics, youth functioning, family
functioning, stress/trauma, and parental psychopathology have been identified in RCTs with
depressed adolescents. Only one study examined moderators of outcome among adolescents
with bipolar disorders. To our knowledge, no RCTs have focused exclusively on school-
aged children with diagnosed mood disorders and examined predictors and moderators of
outcome, until now. Multi-Family Psychoeducational Psychotherapy (MF-PEP) is the sole
psychosocial treatment that has been evaluated and demonstrated efficacy in two RCTs for
school-aged children with diagnosed depression or bipolar disorder. This paper builds upon
primary findings and secondary analyses in the MF-PEP RCT by examining predictors and
moderators of outcome.
Multi-Family Psychoeducational Psychotherapy
MF-PEP is an adjunctive, group-based EBT for children with mood disorders between the
ages of 8 and 12 and their parents (Fristad, Goldberg Arnold, & Leffler, 2011). The
intervention follows a non-blaming, growth-oriented, biopsychosocial model using family
systems and cognitive-behavioral techniques. Psychoeducation, social support, and skills
development are theorized to lead to better understanding and management of mood
disorders and result in improved attainment of and adherence to treatment, as well as
decreased familial conflict and mood symptoms.
MF-PEP consists of eight 90-minute sessions that address mood and comorbid disorders,
medication and psychosocial treatment, emotion regulation, problem-solving, effective
communication, CBT skills, and symptom management. Each session briefly begins and
ends with children and parents together, though families spend the majority of time in
separate and simultaneous parent and child groups. Families are assigned weekly projects to
practice and generalize skills and share with the group the following week. Treatment ends
with a review and graduation ceremony.
Two RCTs demonstrated efficacy of MF-PEP versus waitlist control (WLC). During these
studies, all families were also encouraged to continue TAU for ethical reasons and because
MF-PEP is an adjunctive intervention. The initial RCT of 35 families found that by 6-month
follow-up, parents who immediately received MF-PEP demonstrated improved: family
interactions; knowledge of mood disorders; ability to obtain services; and attitudes towards
treatment (Fristad, Goldberg-Arnold, & Gavazzi, 2002, 2003; Goldberg-Arnold, Fristad, &
Gavazzi, 1999). Children reported increased social support from parents. Also, families
provided positive consumer evaluations. The second RCT included 165 families and found
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that children who immediately received MF-PEP had a significantly greater decrease in
mood symptom severity compared to WLC over 12-month follow-up, with improvement
maintained at 18-month follow-up (Fristad, Verducci, Walters, & Young, 2009).
Mediator analyses in the larger RCT demonstrated that MF-PEP helped parents become
better mental healthcare consumers by increasing knowledge about treatment, which then
lead to attainment of higher quality services (Mendenhall, Fristad, & Early, 2009). When
children received higher quality services that matched their needs, mood symptom severity
decreased.
Finally, two secondary evaluations of comorbidities in the larger MF-PEP RCT found that
the presence of comorbid anxiety and disruptive behaviors did not impact the effect of MF-
PEP on mood symptoms (Boylan, MacPherson, & Fristad, in press; Cummings & Fristad,
2012). Though MF-PEP did not improve anxiety (Cummings & Fristad, 2012) or conduct
disorder symptoms, it was associated with a small reduction in ADHD and oppositional
defiant disorder symptoms (Boylan et al., in press). These findings are promising, given that
adolescent depression RCTs suggest worse outcome among youth with comorbid conditions,
though comborbid anxiety has sometimes been identified as a positive moderator of CBT.
Nevertheless, results suggest that comorbidities may not influence mood severity outcome
for children with mood disorders, and also indicate that predictors and moderators of
treatment may differ between children and adolescents with mood disorders.
Goals of the Study
The goals of the current study were to identify prognostic and conditional indicators in the
larger MF-PEP RCT. This marks the first examination of predictors and moderators in an
RCT of a psychosocial EBT for school-aged children with diagnosed mood disorders. Based
on adolescent RCT findings, we hypothesized that greater child functional impairment
would predict worse outcome. Regarding moderators, we hypothesized that the efficacy of
MF-PEP versus WLC would be reduced among youth with stress/trauma history and parents
with low levels of expressed emotion and high levels of psychopathology. We also pursued
exploratory analyses examining other demographic (i.e., age, sex, race, income), youth
functioning (i.e., intelligence), and mood diagnosis variables, as these are important clinical




This paper conducted secondary data analyses of the larger efficacy MF-PEP RCT (National
Institute of Mental Health Grant R01MH061512), which included 165 children with mood
disorders and their families (Fristad et al., 2009). All study procedures were approved by a
Midwestern university’s Institutional Review Board. MF-PEP participants were recruited
from both rural and urban settings in the Midwest through a previously developed referral
network of local mental health professionals, presentations to local professional and
community-based groups, and local media feature stories about the study. To be eligible,
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children had to be ages 8 to 11 at baseline, have a mood disorder, and have an IQ > 70. Only
one child per family could participate. Informed consent and assent were obtained from
parents and children, respectively.
After determining potential eligibility through a phone screen, the child and a parent, who
was characterized as the primary informant, participated in the baseline assessment.
Subsequently, families were randomized into either a group immediately receiving MF-PEP
(IMM) or a one-year WLC. All children/families were encouraged to continue using TAU
throughout the 18-month study; use of additional interventions was carefully monitored and
has been reported elsewhere (Mendenhall et al., 2009). TAU included medication
management, school-based services, psychotherapy, and other adjunctive interventions, such
as respite care or therapeutic summer camps. TAU was continued for ethical reasons and
also because the mechanism by which MF-PEP improves mood symptoms is due in part to
improved service utilization. Stratified randomization was used after each set of 15 families
completed baseline assessments to ensure equal distributions of mood disorders, comorbid
disorders, and demographic variables. Project coordinators summarized these variables; the
principal investigator completed randomization, but was masked to all other information.
Follow-up assessments were completed by graduate research associates masked to treatment
status. Families participated in follow-up assessments at 6, 12, and 18 months. IMM+TAU
participated in MF-PEP between baseline and 6-month assessments, while WLC+TAU
participated in MF-PEP between 12- and 18-month assessments. All assessments and 22 8-
session MF-PEP groups were conducted at a Midwestern university medical center. Families
received payment for assessments, as well as free parking and child care to enhance
attendance.
Sample size of 165 families was determined a priori based on a power calculation (Cohen,
1988). This sample size would provide 70% power to detect a medium effect size in primary
analyses, including adjustment for multiple comparisons. All children had a mood disorder:
70% (n = 115) had a bipolar spectrum disorder and 30% (n = 50) had a depressive spectrum
disorder. All had comorbid diagnoses, including 97% with behavior disorders and 68% with
anxiety disorders. At baseline, children’s age range was 8 to 11 (M = 9.9, SD = 1.3), with a
majority being male (73%) and White, non-Hispanic (90%). The range of median family
income was $40,000 to $59,000 with 11% of families reporting income of less than $20,000
and 20% reporting income of $100,000 or more. Previous analyses reported baseline
demographic and clinical descriptive statistics for the sample by IMM+TAU and WLC
+TAU, with no significant differences between the two groups (Fristad et al., 2009).
Measures
Primary outcome variable—Primary findings were previously reported (Fristad et al.,
2009). The primary outcome variable, children’s mood symptom severity measured via the
Mood Severity Index (MSI), was assessed at baseline and 6-, 12-, and 18-month follow-ups.
Current analyses used the first three time points. The MSI combines items on the Children’s
Depression Rating Scale – Revised (CDRS-R; Poznanski et al., 1984) and the Mania Rating
Scale (MRS; Young, Biggs, Ziegler, & Meyer, 1978) to provide a single mood severity
variable incorporating manic and depressive symptoms (described below). This was done to
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enhance the power of the study, by using one mood outcome measure as opposed to two,
and as improvement in depression with simultaneous deterioration in mania, or vice versa,
would not represent true improvement in overall mood symptom severity. Of note, the
primary outcome for this study was “adequate clinical response” at 12-month follow-up,
defined as improvement in MSI of ≥ 50%, to differentiate treatment responders versus
nonresponders (Asarnow et al., 2009).
The CDRS-R (Poznanski et al., 1984) is conducted in interview format with parents and
children to assess severity of 17 depressive symptoms in youth. Items use either a 1 to 5 or a
1 to 7 scale, with higher scores indicating increasing severity. Total scores range from 17 to
113. The CDRS-R has demonstrated adequate inter-rater reliability (r = .86), test-retest
reliability (r = .81), and validity (Poznanski et al., 1984).
The MRS (Young et al., 1978) is an 11-item clinical rating scale conducted with parents and
children to assess children’s manic symptoms. Items use either a 0 to 4 or a 0 to 8 scale, with
higher scores indicating increasing severity. Total scores range from 0 (no symptoms) to 60
(severe symptoms). Validity and reliability of the MRS are adequate for adults and children
(Fristad, Weller, & Weller, 1995; Youngstrom, Danielson, Findling, Gracious, & Calabrese,
2002). A study with children found significant internal consistency in MRS ratings (α = .91)
and a one-factor solution from exploratory and confirmatory factor analyses with younger
and older samples of youth (Youngstrom et al., 2002).
An MSI score was calculated with the formula (CDRS-R score- 17 × 11/17) + MRS score.
The formula adjusts for the greater number of items on the CDRS-R and the difference in
minimum scores for the two measures. As irritability is rated on both scales, this item was
down-weighted by half on each measure to avoid double-counting this symptom. The MSI
has a possible score range of 0 to 116 with four symptom severity categories: < 10 =
minimal; 11–20 = mild; 21–35 = moderate; > 35 = severe.
Baseline measures used in analyses—This study used a subset of measures from the
overall MF-PEP dataset (Fristad et al., 2009).
Child functioning: The Children's Global Assessment Scale (CGAS; Shaffer et al., 1983) is
a clinical rating scale used to assess children's functional capacity. Scores range from 1
(severe impairment) to 100 (superior functioning). Reliability and validity are adequate.
The Kaufman Brief Intelligence Test (K-BIT; Kaufman & Kaufman, 1990) is a short
intelligence test based on norms from a nationally standardized sample. It provides an
estimate of overall, verbal, and nonverbal abilities. Reliability and validity have been well-
established.
Family Functioning: The Expressed Emotion Adjective Checklist (EEAC; Friedman &
Goldstein, 1993) is a self-report instrument completed by parents in the current study. It
contains 20 positive and negative descriptors of criticism and emotional overinvolvement
with rating on a 1 (never) to 8 (always) Likert scale. The positive and negative subscale
score totals range from 10 to 80. Items are completed twice, first to record the parent’s
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behavior toward the child, and second to record the child’s behavior toward the parent. The
instrument has been shown to measure expressed emotion comparable to other established
measures.
Stress/Trauma: The Coddington Life Events Scale for Children (Coddington, 1983)
assesses parental report of children’s stressors, ranging from traumatic events to other
significant life changes (e.g., starting a new school, birth of a sibling). It lists 36 stressors,
and a total score quantifies the amount of stress the child has experienced. Higher total
scores indicate a greater number of significant life events. Test-retest reliability and parent-
child agreement are adequate.
The Children’s Interview for Psychiatric Syndromes – Child Form (ChIPS; Weller, Weller,
Rooney, & Fristad, 1999a) and Parent Form (P-ChIPS; Weller, Weller, Rooney, & Fristad,
1999b) are structured diagnostic interviews completed with children and parents,
respectively, which assess psychopathology according to DSM-IV criteria in youth ages 6 to
18. ChIPS and P-ChIPS assess 20 behavioral, anxiety, mood, and other syndromes, as well
as stressors. Adequate reliability and validity have been demonstrated with children and
adolescents, and in inpatient and outpatient research settings (Weller, Weller, Fristad,
Rooney, & Schecter, 2000). In this study, significant inter-rater reliability was obtained (k
= .78 to .82).
Dichotomous items on the ChIPS were used to generate six indices of trauma/stress: Illness;
Arguing; Criticism; Negligence; Physical Abuse; and Sexual Abuse. These indices were
then collapsed to create a Stress/Trauma Index. Only child report was taken into account, as
stress/trauma items asked mainly about parental perpetrators, and social desirability in
parents’ responses may have biased results. Two items comprise Illness: “is someone in your
family very sick;” “has he/she been in the hospital a lot.” Four items comprise Arguing: “is
there a lot of arguing or fighting in your family;” “is arguing mostly among the children/
teenagers;” “is there arguing between your mom and dad;” and “is there arguing between
your parents and you and/or your brother(s)/sister(s).” Three items comprise Criticism:
“does your mother/father criticize you a lot;” “does your mother/father ever say that he/she
wishes you had not been born;” and “does your mother/father tell you that she/he doesn’t
like you or that she/he hates you.” Four items comprise Negligence: “does your mother/
father ignore you a lot;” “do you miss doctor’s appointments because your mother/father
doesn’t bother to get you there;” “do you not have meals because your mother/father
doesn’t bother to make them (not because of lack of money);” “do you not have other things
you need, like clothes, because your mother/father hasn’t bothered to get them for you;” and
“has your mother/father ever made you go for a whole day without eating as punishment.”
Four items comprise Physical Abuse: “when you do something wrong, are you spanked or
hit;” “do you sometimes get hit or spanked for no good reason (just because your mother/
father is mad and you just happen to be around);” “are you afraid your mother/father will
hurt you very badly when she/he punishes you;”and “has your mother/father ever physically
punished you so hard that you hurt the next day, or you had bruises or marks on your body,
or you had to see a doctor.” Finally, one item measures Sexual Abuse: “has anyone ever
tried to undress you, touch you between the legs, make you get in bed with him or her, or
make you play with his or her private parts.”
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Excluding Illness, the remaining indices demonstrated significant positive correlations with
each other (rs = .27 to .74). After Principal Component Analysis, a single factor emerged
explaining 55% of the variance. This single factor demonstrated good internal consistency
(Cronbach’s α = .74).
Parental Psychopathology: The Psychiatric Diagnostic Interview – Revised (PDI-R;
Othmer, Penick, Powell, Read, & Othmer, 1989) is a structured diagnostic interview used to
assess 17 psychiatric diagnoses and symptoms. Reliability and validity are acceptable.
The Hamilton Rating Scale for Depression (HRSD; Hamilton, 1967) is a 24-item clinical
rating scale that was used to assess parents’ depressive symptom severity. Total scores range
from 0 to 72. This instrument has demonstrated high inter-rater reliability and adequate
levels of validity (Hedlund & Vieweg, 1979).
Parents were also administered the MRS (Young et al., 1978) to assess manic symptom
severity. As described previously, 11 items yield total scores ranging from 0 to 60 with
increasing severity, and reliability and validity are adequate for adults, the age group for
which the instrument was originally designed.
The Structured Clinical Interview for DSM-IV Axis II Personality Disorders – Patient
Questionnaire (SCID-II-PQ; First, Gibbon, Spitzer, Williams, & Benjamin, 1997) is a self-
report screener with 119 yes/no items that typically accompanies the SCID II structured
interview. It assesses Axis II personality disorders according to DSM-IV criteria. The SCID-
II-PQ has demonstrated adequate diagnostic agreement when compared with the SCID II
structured interview (Ekselius, Lindstrom, von Knorring, Bodlund, & Kullgren, 1994).
Analyses
As aforementioned, and consistent with prior adolescent depression RCT predictor and
moderator methodology (Asarnow et al., 2009), the primary outcome for this study was
“adequate clinical response” at 12-month follow-up, defined as improvement in MSI of ≥
50%. Youth meeting this criterion were categorized as responders, while youth not meeting
this criterion were considered nonresponders. All analyses were intent-to-treat and used the
Multiple Imputation procedure for missing longitudinal values, imputing 10 sets of values
(Rubin, 1996).
As outlined by Kraemer et al. (2002), predictors were defined as baseline variables that had
a main effect on outcome regardless of group (IMM+TAU or WLC+TAU). Predictor
analyses proceeded in two steps. First, independent sample t tests and χ2 analyses were
conducted to examine which of the candidate explanatory variables were associated with
adequate versus inadequate treatment response. Then, variables significantly associated with
outcome were entered into a logistic regression predicting treatment response, controlling
for age, sex, and race.
Moderators, defined as baseline variables that had interactive effects with group assignment
(IMM+TAU or WLC+TAU) on outcome, were then examined (Kraemer et al., 2002).
Specifically, linear mixed effects modeling (LME) was used to analyze the moderating
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effect of variables measured at the baseline assessment, and that were identified as
predictors in previous analyses, on the impact of MF-PEP on children’s mood symptom
severity. LME accounts for outcome changes over time in a nested dataset and models
repeated measures with subject-specific regression coefficients that are parameters allowed
to vary over individuals (Singer & Willett, 2003). The current analyses used the full MF-
PEP sample and compared children’s mood symptom severity in IMM+TAU and WLC
+TAU using an LME model with fixed slopes and random intercepts by participant.
Moderation was evaluated via treatment X baseline predictor X time interactions.
Thus, regarding predictor hypotheses, improvement slope for children’s mood symptom
severity, regardless of treatment group, was expected to be steepest among children with
higher global functioning. Regarding moderators, improvement slope for children’s mood
symptoms was hypothesized to be steepest among children in IMM+TAU (versus WLC
+TAU) with no stress/trauma history and parents’ with high levels of expressed emotion and
low levels of psychopathology. Exploratory variables (i.e., age, sex, race, income,
intelligence, mood diagnosis) were also examined.
Analyses were run using SPSS 19.0. Despite multiple comparisons, α was set at .05 (two-
sided) due to the exploratory nature of analyses.
Results
Recruitment and follow-up assessments were conducted from 2001 to 2005. The primary
study ended following completion of all follow-up assessments. Figure 1 summarizes
participant flow of the MF-PEP RCT. Current study hypotheses concerned the effect of
predictive and moderating variables (i.e., demographic, youth functioning, family
functioning, stress/trauma, paternal psychopathology) on children’s mood symptom severity
at follow-up assessments in the MF-PEP RCT. Approximately 17% (n = 28) of the entire
sample had at least one missing value in these potential predictors and moderators at
baseline. When those with missing data were compared to those without missing data on the
MSI, no significant differences were observed [t (163) = 0.15, p>.05].
Predictors
Nonresponse (versus adequate clinical response) was significantly associated with higher
baseline levels of global functioning in children (Cohen’s d = 0.51) and Cluster B
personality disorder symptoms in parents (d = 0.49). Nonresponse was also significantly
associated with lower baseline levels of stress/trauma in children (d = 0.56), especially
negligence (d = 0.56), physical abuse (d = 0.45), and arguing (d = 0.34). Stated differently,
treatment responders had significantly lower global functioning (i.e., greater impairment),
higher levels of stress/trauma, and parents with lower levels of Cluster B personality
disorder symptoms (see Table 1). Logistic regression adjusting for age, sex, and race
indicated that the most parsimonious baseline predictors were children’s global functioning
and stress/trauma (see Table 2). Specifically, logistic regression confirmed that the
likelihood of adequate clinical response increased as baseline levels of children’s global
functioning decreased and stress/trauma increased.
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Based on hypothesized moderators, calculated confidence intervals from logistic regression,
and the exploratory nature of these analyses, a series of linear mixed effects regression
models using the intent-to-treat cohort of 165 participants tested the moderating effects of
children’s global functioning and stress/trauma history, and parents’ expressed emotion and
Cluster B personality disorder symptoms, on the treatment effect of MF-PEP. Linear mixed
effects regression models found that global functioning was the only variable that
significantly moderated effects of MF-PEP on children’s mood symptom severity (see Table
3). The model focusing on children’s global functioning revealed a three-way interaction
between treatment group, CGAS, and time (F1, 293.5 = 4.061, p = .045) on MSI scores,
indicating a differential treatment effect for children with low versus high global
functioning. Specifically, for children with severely impaired CGAS scores (≤ 35), the
estimated slope was −10.28 (95% confidence interval [CI] −13.47 to −7.09) for IMM+TAU
and −4.02 (95% CI −7.10 to −0.95) for WLC+TAU. For children with relatively high CGAS
scores (≥ 52), the estimated slope was −0.06 (95% CI −3.22 to 3.09) for IMM+TAU and
−0.10 (95% CI −2.70 to 2.49) for WLC+TAU. Thus, higher global functioning among
children was associated with less severe mood symptom severity in the MF-PEP group prior
to treatment and a smaller overall treatment effect (see Figure 2). Based on this model,
children with relatively high CGAS scores of ≥ 52, which is one standard deviation above
the mean for the entire sample (M = 43.74, SD = 8.41), would have little or no treatment
effect from participation in MF-PEP (t = 0.27, d = 0.04). However, children with moderately
impaired CGAS scores of 36 to 51 (which includes the average CGAS score of 44 plus or
minus one standard deviation) in IMM+TAU versus WLC+TAU had significantly decreased
mood symptom severity as a result of MF-PEP (t = 2.10, d = 0.33). MF-PEP had an even
stronger effect on mood symptoms for children with severely impaired CGAS scores of ≤
35, which is one standard deviation below the mean (t = 3.03, d = 0.47).
Linear mixed effects regression models found that the following variables did not moderate
the effects of MF-PEP on children’s mood symptom severity: children’s stress/trauma
history (F1, 296.1 = 1.432, p = .232); parental expressed emotion (F1, 271.3 = 1.097, p = .296);
and parental Cluster B personality disorder symptoms (F1, 307.4 = 0.204, p = .652).
Discussion
The current study marks the first investigation of predictors and moderators in an RCT of a
psychosocial EBT, MF-PEP, for childhood mood disorders. Findings indicated that
treatment responders had significantly lower global functioning (i.e., greater impairment),
higher levels of stress/trauma, and parents with lower levels of Cluster B personality
disorder symptoms. Children’s global functioning also moderated the treatment effect of
MF-PEP. Specifically, MF-PEP had a smaller impact on mood symptoms for children who
at baseline were higher functioning, albeit clearly still within the clinical range (CGAS ≥
52). MF-PEP had the strongest effect on mood symptoms for severely impaired children
(CGAS ≤ 35). These findings are discussed within the context of adolescent mood disorder
RCT predictor and moderator results and study limitations.
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In keeping with findings in RCTs of EBTs for depressed adolescents, we hypothesized that
greater functional impairment would predict treatment nonresponse (Asarnow et al., 2009;
Curry et al., 2006; Emslie et al., 2010; Jayson et al., 1998; Rohde et al., 2006; Vitiello et al.,
2011; Wilkinson et al., 2009). However, functional impairment predicted outcome in the
opposite direction: youth with lower functioning benefitted more from treatment.
Subsequent analyses, which revealed that children’s global functioning was a moderator in
the RCT, shed some light on surprising impairment findings. MF-PEP had a smaller
treatment effect for children with higher global functioning at baseline. Since children with
higher levels of global functioning tended to have less severe mood symptoms at baseline,
these children had less room for improvement following the MF-PEP intervention and may
have already been utilizing some of the presented skills, minimizing a potential treatment
effect. Conversely, families of children with lower levels of global functioning at baseline
experienced greater improvement in children’s symptom severity, suggesting MF-PEP was
effective in providing the education and skills needed by families with children who were
most impaired. More specifically, these results suggest that MF-PEP may be most impactful
for children with at least moderate functional impairment (CGAS ≤ 51), as there was little to
no treatment effect for children functioning at a CGAS level higher than this. Severely
impaired children (CGAS ≤ 35) showed the most improvement in mood symptoms. Though
not initially hypothesized, some adolescent depression RCTs found greater impairment,
conceptualized as indicators of more severe depression (Barbe et al., 2004a; Rohde et al.,
2006) or comorbidities (Asarnow et al., 2009; Brent et al., 1998), to be a positive moderator
of CBT. Although functional impairment typically predicts worse prognostic outcome in
adolescent studies, cumulating evidence suggests that these variables may actually moderate
treatment, with more impaired youth exhibiting greater response to CBT-based
interventions.
Other unexpected predictors of outcome included stress/trauma and parental
psychopathology. In line with findings from adolescent depression RCTs (Asarnow et al.,
2009; Brent et al., 1998; Barbe et al., 2004b; Lewis et al., 2010: Shamseddeen et al., 2011),
we expected these variables to moderate the treatment effect of MF-PEP, in that youth with
stress/trauma history and parents with high levels of psychopathology would respond more
poorly to MF-PEP. However, these variables functioned solely as main effects. Youth with
parents with high levels of Cluster B personality disorder symptoms experienced worse
outcome. Though not initially hypothesized, this finding intuitively makes sense. Research
has consistently documented considerable impairment among adults with Cluster B
personality disorders, especially borderline personality disorder (Leichsenring, Leibing,
Kruse, New, & Leweke, 2011). Severely impaired parents in WLC+TAU may have been
unable to access appropriate services for their children or follow-through with treatment
recommendations, while impaired parents in MF-PEP+TAU may have been unable to
effectively utilize therapeutic skills and help their children generalize techniques, especially
if they were not seeking their own mental health treatment. Interestingly, parents’ general
psychiatric and mood symptoms were not related to outcome, despite research
demonstrating associations between treatment of parents’ depression and improvement in
children’s psychiatric symptoms (Gunlicks & Weissman, 2008). Thus, although prior
research suggests that treatment of parents’ mood symptoms may offer added benefit for
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youth, our findings indicate that improvement in children’s mood is not necessarily
compromised by presence of parental psychiatric and mood symptoms pre-treatment.
Stress/trauma also functioned as a main effect, but in an unexpected direction: youth with
history of stress/trauma experienced more improved outcomes. This is contrary to most
adolescent depression RCTs (Asarnow et al., 2009; Barbe et al., 2004b; Lewis et al., 2010;
Shamseddeen et al., 2011) and mood disorder outcome literature in general (Nanni, Uher, &
Danese, 2012), which found stress/trauma history to be a negative moderator or predictor of
outcome, respectively. However, findings are somewhat consistent with adult literature,
which demonstrated that chronically depressed adults with maltreatment histories
preferentially responded to psychotherapy versus medication (Nemeroff et al., 2003). In the
current study, stress/trauma history was largely conceptualized within the family context,
with significant stress/trauma primarily consisting of arguing, negligence, and physical
abuse. As all children received TAU, and as treatment of childhood mood disorders often
involves family members (and this is certainly emphasized in MF-PEP), these treatments
may have incorporated a familial component. Thus, parents who previously argued with,
neglected, or abused their children may have developed more effective parenting strategies
as a result of MF-PEP and/or TAU, subsequently enhancing mood outcome. Similarly,
children’s stress/trauma history may have exacerbated mood symptoms at baseline, thus
allowing more room for improvement following treatment. In addition, primary outcomes
were at 12-month follow-up, not post-treatment. Thus, stress/trauma history may be a
negative predictor or moderator of acute treatment outcome, but enhance outcomes over
follow-up, during which children receive additional services.
Lastly, parental EE neither predicted nor moderated outcomes. This is contrary to
hypotheses and findings from adolescent mood disorder RCTs, which found poor familial
environment to predict worse outcome (Asarnow et al., 2009; Birmaher et al., 2000; Brent et
al., 1999; Clarke et al., 1992; Emslie et al., 2010; Feeny et al., 2009; Rohde et al., 2006), or
to moderate treatment response, with impaired families benefiting more from psychosocial
intervention (Gunlicks-Stoessel et al., 2010; Miklowitz et al., 2009). Though surprising, this
finding is promising, as it suggests that youth from families of varied environments
responded equally well to treatment, with outcome unaffected by pretreatment familial
factors. It may be that familial interaction styles among children with mood disorders, as
opposed to adolescents, are less ingrained and more amenable to treatment, and that –
regardless of dysfunction within the family – applied treatments can be helpful.
Finally, exploratory demographic (i.e., age, sex, race, income), youth functioning (i.e.,
intelligence), and mood diagnosis variables did not predict or moderate outcome. Past
research demonstrated older adolescents typically fared worse in CBT RCTs (Brent et al.,
1998; Clarke et al., 1992; Curry et al., 2006; Jayson et al., 1998). As the MF-PEP sample
included only school-aged children, truncated age range may have limited the ability to
detect differences; alternately, it may be that children’s age does not influence outcome.
Similarly, sex and race have inconsistently affected outcome in the adolescent literature
(Asarnow et al., 2009; Curry et al., 2006; Curry et al., 2011; Rohde et al., 2006). As the MF-
PEP sample was predominantly male and Caucasian, limited diversity may have hindered
the ability to detect differences. Income moderated outcome in only one adolescent
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depression study (Curry et al., 2006), and did not affect outcome in the current trial; thus,
income may not be a robust moderator. Cognitive abilities also did not impact change in
mood symptom severity, though this is not terribly surprising, as inclusion criteria in the
current study limited variability (IQ > 70), and another study found verbal intelligence did
not impact treatment response (Curry et al., 2006). Interestingly, mood diagnosis did not
affect outcome, which is promising, as it suggests that treatment response was equivalent
regardless of diagnosis. However, as the sample consisted primarily of youth with bipolar
disorders, lack of variability may have limited this finding. Thus, some interesting and
unexpected findings in the current study highlight considerations for clinical practice and
inform areas of future research.
Implications for Research, Policy, and Practice
This study has important implications regarding effective treatment of childhood mood
disorders. Findings emphasize the importance of comprehensive assessment prior to
treatment initiation. Regarding prognostic indicators, low functioning youth with stress/
trauma histories and parents with low levels of Cluster B personality disorder symptoms
may fare well with TAU and MF-PEP; however, additional and/or different interventions
may be required for higher functioning youth without stress/trauma histories and with
parents with high levels of Cluster B personality disorder symptoms. For children with
severe global impairment, psychoeducational interventions, such as MF-PEP, may be
especially effective and more impactful than available treatments.
These findings also lend support for currently employed treatments (i.e., TAU) and
psychoeducational interventions (i.e., MF-PEP) in treatment of childhood mood disorders,
regardless of various demographic, youth, parental, and family functioning pretreatment
characteristics. For example, in this study, treatment response was unaffected by children’s
demographic status, cognitive abilities, and mood diagnosis, parents’ general psychiatric and
mood symptoms, and familial expressed emotion. Though somewhat surprising, these
findings are promising and suggest that positive treatment response may not be impeded by
these variables. Thus, while thorough assessment evaluating all aforementioned variables is
necessary to inform treatment, attention to children’s stress/trauma histories and functional
impairment, and parental psychopathology (particularly Cluster B personality disorder
symptoms), may be especially important to consider when selecting effective treatment for
childhood mood disorders.
Regarding MF-PEP in particular, the content and format are effective for children with
varied demographics, comorbidities, familial and parental backgrounds, and functioning. In
fact, MF-PEP may be most effective for the most impaired children. Thus,
psychoeducational treatments and other family-based interventions are likely to be
applicable and beneficial in clinical settings.
Limitations
Limitations relate to the sample, measured variables, design, and assessment instruments.
The sample lacked diversity (73% male and 90% White, non-Hispanic), and therefore may
not be representative of the population of children with mood disorders. In addition,
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characteristics of families who seek clinical trials may differ from those in a general clinic
sample. In particular, although parents in the current study reported a robust history of mood
symptoms, their symptom severity at baseline was not notable. Thus, these parents may have
been more resourceful in acquiring services for themselves and their children, and may have
been more stable and capable at the time of the study. Also, greater diversity in the sample
may have revealed demographic variables as predictors and moderators. Similarly, other
variables such as resiliency, coping strategies, communication skills, and other indicators of
severity (i.e., suicidality, hopelessness) may be important predictors or moderators of
treatment, but were not specifically measured. Thus, research including diverse samples in
general practice settings and measurement of other potentially important variables that may
affect outcome is needed.
Attrition at follow-up assessments limited statistical power. Thus, the mood symptom
severity of the sample analyzed at later time points may not be representative of the original
sample and therefore may have produced biased results. In addition, MF-PEP+TAU was
compared to WLC+TAU, rather than to a placebo or another uniquely active treatment;
therefore, conclusions cannot be drawn about the specific components of MF-PEP compared
to other interventions. Additionally, most measures of examined predictors and moderators
relied solely on parent report (with the exception of stress/trauma), which may have been
problematic for parents suffering from psychopathology. Parents with emotional or
behavioral disturbance may have had impaired judgment in reporting their child’s or their
own symptoms, potentially affecting predictor and moderator findings. Thus, future research
containing additional semi-structured assessments, incorporating information from multiple
informants, may provide more unbiased measurement of variables of interest. Despite these
limitations, this study provides important findings regarding treatment of childhood mood
disorders and indicates areas in need of further research.
Conclusions
Comprehensive evaluation should be conducted prior to treatment of childhood mood
disorders. Clinicians should especially consider children’s stress/trauma history and global
functioning, as well as parental psychopathology. Specifically, youth with high global
functioning, without stress/trauma history, and with parents with high levels of Cluster B
personality disorder symptoms may fare more poorly in both MF-PEP and currently offered
treatments, and thus may require additional and/or different interventions. In addition, youth
with severe functional impairment may experience the most benefit in mood symptoms from
psychoeducational interventions, such as MF-PEP. Thus, findings support the use of
thorough pretreatment assessments to inform prognostic indicators and guide intervention
selection, as well as implementation of family-based psychoeducational treatments in
practice settings, given the demonstrated efficacy of MF-PEP for impaired children’s mood
symptoms, regardless of children’s demographic status, cognitive abilities, and mood
diagnosis, parents’ general psychiatric and mood symptoms, and familial expressed emotion.
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CONSORT randomized trial flow diagram. IMM = immediate treatment group; WLC = waitlist control group; TAU = treatment
as usual; Treatment Completers = completed ≥ 6 sessions; ITT = intent-to-treat. CGAS= Children’s Global Assessment Scale
score.
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Effect of Multi-Family Psychoeducational Psychotherapy on children’s mood symptom severity as moderated by children’s
current global functioning. CGAS= Children’s Global Assessment Scale.
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Table 1
Predictors of Adequate versus Inadequate Response
Nonresponders
(n = 115), 70%
Responders
(n = 50), 30%
χ2 or t-test Cohen’s
d
Demographics, n (%)
  Age, M (SD) 9.8 (1.2) 9.9 (1.3) 0.47 0.08
  Sex (male) 82 (71.3) 39 (78.0) χ2(1) = 0.80 0.14
  Race (white) 105 (91.3) 45 (90.0) χ2(1) = 0.07 0.04
  Family Income (≥ $60,000) 56 (48.6) 23 (46.0) χ2(1) = 0.10 0.05
Child Mood Diagnosis, n (%)
  DSD (ChIPS & P-ChIPS) 33 (28.7) 17 (34.0) χ2(1) = 0.46 0.10
  BPSD (ChIPS & P-ChIPS) 82 (71.3) 33 (66.0)
Child Functioning, M (SD)
  Global Functioning (CGAS) 44.9 (7.5) 41 (7.6) 3.03*** 0.51
  Overall Intelligence (KBIT) 106.3 (14.3) 107.8 (16.0) −0.59 0.10
    Verbal Intelligence 103.7 (12.6) 103.5 (14.7) 0.08 0.01
    Visual-Spatial Intelligence 107.6 (16.5) 110 (16.6) −0.85 0.14
Family Functioning, M (SD)
  Child Expressed Emotion (EEAC) −4 (17.1) .66 (21.0) −1.37 0.25
  Parent Expressed Emotion (EEAC) 33.1 (15.6) 31.6 (17.0) 0.54 0.09
Stress/Trauma, M (SD)
  Stressful Life Events (Coddington) 189.4 (117.3) 158.9 (93.0) 1.76 0.27
  Stress/Trauma Index (ChIPS) 3.12 (2.99) 5.11 (4.51) −2.83** 0.56
    Illness 0.94 (0.86) 0.89 (0.86) 0.34 0.06
    Arguing 1.6 (1.4) 2.1 (1.6) −2.00* 0.34
    Criticism 0.42 (0.67) 0.71 (1.0) −1.85 0.36
    Negligence 0.30 (0.89) 0.90 (1.4) −2.76** 0.56
    Physical Abuse 0.63 (0.97) 1.1 (1.2) −2.42* 0.45
    Sexual Abuse (yes), n (%) 15 (13.0) 12 (24.0) χ2(1) = 3.06 0.27
Parental Psychopathology, M (SD)
  Psychiatric Disorders (PDI-R) 0.88 (1.21) 0.64 (0.94) 1.36 0.21
  Psychiatric Symptoms (PDI-R) 0.85 (0.97) 0.75 (0.83) 0.63 0.11
  Depression Symptoms (HRSD) 8.6 (8.0) 6.7 (6.1) 1.65 0.25
  Mania Symptoms (MRS) 20.2 (11.1) 21.4 (9.7) −0.65 0.11
  Cluster A PD Symptoms (SCID-II-PQ) 0.19 (0.16) 0.15 (0.13) 1.67 0.26
  Cluster B PD Symptoms (SCID-II-PQ) 0.13 (0.14) 0.08 (0.08) 2.87** 0.40
  Cluster C PD Symptoms (SCID-II-PQ) 0.38 (0.24) 0.32 (0.19) 1.70 0.26
Note. DSD = Depressive Spectrum Disorder; BPSD = Bipolar Spectrum Disorder; ChIPS & P-ChIPS = Children’s Interview for Psychiatric
Syndromes – Child Form and Parent Form; CGAS = Children’s Global Assessment Scale; K-BIT = Kaufman Brief Intelligence Test; EEAC =
Expressed Emotion Adjective Checklist; Coddington = Coddington Life Events Scale for Children; PDI-R = Psychiatric Diagnostic Interview –
Revised; HRSD = Hamilton Rating Scale for Depression; MRS = Mania Rating Scale; SCID-II-PQ = Structured Clinical Interview for DSM-IV
Axis II Personality Disorders, Patient Questionnaire.




























p < 0.005, two-tailed
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